The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Celsius (NASDAQ:CELH) and the rest of the beverages and alcohol stocks fared in Q4.
These companies’ performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the explosion of alcoholic craft beer drinks or the steady decline of non-alcoholic sugary sodas. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players.
The 14 beverages and alcohol stocks we track reported a weaker Q4; on average, revenues were in line with analyst consensus estimates. while next quarter’s revenue guidance was 20.2% below consensus. Stocks have faced challenges as investors prioritize near-term cash flows, but beverages and alcohol stocks held their ground better than others, with share prices down 3% on average since the previous earnings results.
Celsius (NASDAQ:CELH)
With its proprietary MetaPlus formula as the basis for key products, Celsius (NASDAQ:CELH) offers energy drinks that feature natural ingredients to help in fitness and weight management.
Celsius reported revenues of $347.4 million, up 95.2% year on year, topping analyst expectations by 4.8%. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates.
Celsius pulled off the fastest revenue growth of the whole group. The stock is up 24.8% since the results and currently trades at $84.45.
Best Q4: Vita Coco (NASDAQ:COCO)
Founded in 2004 followed by a 2021 IPO, The Vita Coco Company (NASDAQ:COCO) offers coconut water products that are a natural way to quench thirst.
Vita Coco reported revenues of $106.1 million, up 15.4% year on year, outperforming analyst expectations by 7%. It was a very strong quarter for the company, with an impressive beat of analysts’ earnings and revenue estimates. On the other hand, its full-year revenue guidance was underwhelming. However, adjusted EBITDA guidance came in ahead, which is sure to blunt the impact of the below-Consensus revenue guidance.
Vita Coco pulled off the biggest analyst estimates beat and highest full-year guidance raise among its peers. The stock is up 13.7% since the results and currently trades at $25.5.
Is now the time to buy Vita Coco? Access our full analysis of the earnings results here, it’s free.
Weakest Q4: Boston Beer (NYSE:SAM)
Known for its flavorful beverages challenging the status quo, Boston Beer (NYSE:SAM) is a pioneer in craft brewing and a symbol of American innovation in the alcoholic beverage industry.
Boston Beer reported revenues of $393.7 million, down 12% year on year, falling short of analyst expectations by 4.8%. It was a weak quarter for the company, with a miss of analysts’ revenue and EPS estimates.
Boston Beer had the slowest revenue growth in the group. The stock is down 20.7% since the results and currently trades at $293.14.
Read our full analysis of Boston Beer’s results here.
Constellation Brands (NYSE:STZ)
With a presence in more than 100 countries, Constellation Brands (NYSE:STZ) is a globally renowned producer and marketer of beer, wine, and spirits.
Constellation Brands reported revenues of $2.47 billion, up 1.4% year on year, falling short of analyst expectations by 2.6%. It was a weak quarter for the company, with underwhelming earnings guidance for the full year.
The stock is up 10.4% since the results and currently trades at $267.43.
Read our full, actionable report on Constellation Brands here, it’s free.
Keurig Dr Pepper (NASDAQ:KDP)
Born out of a 2018 merger between coffee company Keurig Green Mountain and beverage company Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ:KDP) boasts a powerhouse portfolio of beverages.
Keurig Dr Pepper reported revenues of $3.87 billion, up 1.7% year on year, falling short of analyst expectations by 1%. It was a weaker quarter for the company, with a miss of analysts’ revenue estimates.
The stock is down 3.4% since the results and currently trades at $30.56.
Read our full, actionable report on Keurig Dr Pepper here, it’s free.
Join Paid Stock Investor Research
Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.